CHEMICAL COMPOSITION OF A COLLECTOR-DRAINAGE RUNOFF IN OPEN CANALS IN SEMIKARAKORSKY DISTRICT

by T. I. Drovovozova, T. Yu. Kokina, S. A. Maryash, Ye. S. Kulakova
Published 2019-11-01

Outcomes of liver transplantation in the era of modern antiviral therapy for hepatitis C

by K. Yu. Kokina, Yu. O. Malinovskaya, Ya. G. Moysyuk
Published 2021-04-01

Genetic Aspects of Non-Alcoholic Fatty Liver Disease

by Pavel O. Bogomolov, Kseniya Yu. Kokina, Aleksander Yu. Mayorov, Ekaterina E. Mishina
Published 2019-01-01

Severe Clostridium diffi cile infection after liver and kidney transplantation

by K. Yu. Kokina, Yu. O. Malinovskaya, A. B. Sidorenko, Ya. G. Moisyuk
Published 2019-12-01

Predictors of the efficiency of short-term interferon-containing therapy using direct-acting antiviral drugs in patients with chronic hepatitis C virus genotype 1

by K Yu Kokina, A O Bueverov, P O Bogomolov, M V Matsievich
Published 2017-12-01

ANTIVIRAL THERAPY IN LIVER CIRRHOSIS

by P. O. Bogomolov, M. V. Matsievich, S. V. Koblov, M. Yu. Petrachenkova, K. Yu. Kokina
Published 2016-02-01

Clinical aspects of using artificial intelligence for the interpretation of chest X-rays

by S. P. Morozov, D. Yu. Kokina, N. A. Pavlov, Yu. S. Kirpichev, V. A. Gombolevskiy, A. E. Аndreychenko
Published 2021-05-01

Liver cirrhosis in the Moscow Region: figures and facts

by P. O. Bogomolov, M. V. Matsievich, A. O. Bueverov, K. Yu. Kokina, N. V. Voronkova, V. D. Beznosenko
Published 2018-04-01

CHRONIC HEPATITIS B VIRUS INFECTION IN PREGNANCY: STRATEGIES OF ANTIVIRAL THERAPY

by P. O. Bogomolov, M. V. Matsievich, K. Yu. Kokina, N. V. Voronkova, O. S. Kuz'mina, A. O. Bueverov
Published 2016-02-01

EXPRESSION OF TLR2, TLR3, TLR4 AND PROINFLAMMATORY TNF AND IL-6 CYTOKINES IN LIVER BIOPSIES OF NONALCOHOLIC FATTY LIVER DISEASE PATIENTS

by A. V. Bogolyubova, E. E. Mishina, P. O. Bogomolov, M. V. Matsievich, K. Yu. Kokina, A. Yu. Mayorov, P. V. Belousov
Published 2019-12-01

Epidemiology of hepatitis C in the Moscow Region: data from the Moscow Regional Registry and screening for HCV antibodies

by P. O. Bogomolov, A. O. Bueverov, M. V. Matsievich, M. Yu. Petrachenkova, N. V. Voronkova, S. V. Koblov, K. Yu. Kokina, V. D. Beznosenko, E. V. Fedosova
Published 2016-09-01

Efficacy and safety of 3D-therapy at HCV-related subcompensated liver cirrhosis (genotype 1b)

by P. O. Bogomolov, M. V. Matsiyevich, A. O. Buyeverov, V. D. Beznosenko, Ye. V. Fedosova, M. Yu. Petrachenkova, S. V. Koblov, K. Yu. Kokina, O. S. Kuzmina, N. V. Voronkova
Published 2018-08-01

A SHORT COURSE OF TRIPLE TELAPREVIR-BASED ANTIVIRAL THERAPY: THE PRINCIPLES OF PATIENTS SELECTION

by P. O. Bogomolov, M. V. Matsievich, K. Yu. Kokina, O. S. Kuz'mina, S. V. Koblov, N. V. Voronkova, M. Yu. Petrachenkova, A. O. Bueverov, O. V. Uvarova, E. V. Fedosova, M. N. Trofimova, V. D. Beznosenko, E. N. Kudryavtseva, E. M. Kondratenko, L. S. Gorbunova, I. M. Shilkina, T. N. Sheshukova, I. N. Kovalev, G. V. Sadovskaya, N. V. Kosheleva, Yu. Yu. Gumerova, I. N. Azarova, S. V. Ivannikova, E. N. Cherenkova, N. A. Gorshilina, M. L. Samsonyan, V. A. Sinitsyna, S. I. Kiyan, O. A. Kudrya, G. G. Chernyavskaya
Published 2016-02-01